Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: J Bone Miner Res. 2017 Jun 26;32(9):1945–1955. doi: 10.1002/jbmr.3183

Table 2.

Percent change in BMD at the spine (L1–L4), hip and femoral neck, compared between the immediate and deferred ART groups by intent-to-treat.

Spine (L1–L4) Immediate ART Group Deferred ART Immediate - Deferred ART Groups
N Mean (95% CI) N Mean (95% CI) Estimated Difference (95% CI) P
Baseline to Year 1 194 −2.04 (−2.46, −1.62) 197 −0.32 (−0.71, 0.07) −1.72 (−2.29, −1.14) <0.001
Baseline to Year 2 169 −1.74 (−2.28, −1.21) 180 −0.33 (−0.87, 0.22) −1.41 (−2.18, −0.65) <0.001
Baseline to Year 3 51 −2.45 (−3.41, −1.48) 59 −0.29 (−1.33, 0.75) −2.16 (−3.60, −0.71) <0.01

Overall 195 −1.92 (−2.34, −1.50) 204 −0.35 (−0.76, 0.06) −1.57 (−2.16, −0.98) <0.001

Change from Year 1 to Year 2 (%) 168 0.29 (−0.16, 0.74) 173 −0.10 (−0.54, 0.35) 0.39 (−0.25, 1.03) 0.23
Change from Year 2 to Year 3 (%) 50 0.25 (−0.54, 1.03) 59 −0.49 (−1.21, 0.23) 0.78 (−0.31, 1.86) 0.16

Rate of change after Year 1 (% per year) 0.24 (−0.11, 0.59) −0.17 (−0.51, 0.16) 0.42 (−0.07, 0.90) 0.10

Total Hip

Baseline to Year 1 193 −2.03 (−2.57, −1.50) 197 −0.49 (−0.87, −0.11) −1.54 (−2.21, −0.88) <0.001
Baseline to Year 2 169 −2.93 (−3.62, −2.23) 180 −1.30 (−1.90, −0.69) −1.58 (−2.50, −0.65) <0.001
Baseline to Year 3 51 −3.58 (−4.46, −2.70) 58 −1.94 (−3.14, −0.73) −1.57 (−3.09, −0.04) 0.05

Overall 194 −2.53 (−3.03, −2.02) 204 −0.99 (−1.48, −0.49) −1.53 (−2.24, −0.82) <0.001

Change from Year 1 to Year 2 (%) 168 −0.97 (−1.45, −0.49) 173 −0.81 (−1.28, −0.34) −0.11 (−0.79, 0.57) 0.75
Change from Year 2 to Year 3 (%) 50 0.03 (−0.64, 0.69) 58 −0.96 (−1.58, −0.34) 1.03 (0.11, 1.95) 0.03

Rate of change after Year 1 (% per year) −0.74 (−1.12, −0.36) −0.84 (−1.20, −0.47) 0.15 (−0.38, 0.68) 0.58

Femoral Neck

Baseline to Year 1 193 −2.49 (−3.11, −1.86) 197 −0.62 (−1.15, −0.08) −1.96 (−2.78, −1.14) <0.001
Baseline to Year 2 169 −3.41 (−4.27, −2.54) 180 −2.02 (−2.78, −1.27) −1.46 (−2.61, −0.32) 0.01
Baseline to Year 3 51 −3.66 (−5.08, −2.25) 58 −2.36 (−3.78, −0.95) −1.32 (−3.34, 0.69) 0.20

Overall 194 −3.02 (−3.64, −2.40) 204 −1.44 (−2.05, −0.83) −1.70 (−2.57, −0.83) <0.001

Change from Year 1 to Year 2 (%) 168 −1.00 (−1.63, −0.37) 173 −1.46 (−2.08, −0.84) 0.46 (−0.42, 1.35) 0.30
Change from Year 2 to Year 3 (%) 50 −0.32 (−1.37, 0.74) 58 −0.58 (−1.56, 0.40) 0.25 (−1.21, 1.71) 0.74

Rate of change after Year 1 (% per year) −0.87 (−1.37, −0.38) −1.23 (−1.70, −0.75) 0.36 (−0.33, 1.06) 0.30

Follow-up was censored at the start of osteoporosis therapy for 2 participants (both in the deferred group, month 24). Mean changes in BMD from baseline to each year were calculated without adjustments, differences at each year were estimated in regression models adjusted for baseline BMD, and overall changes in BMD were estimated and compared using longitudinal mixed models adjusted for both baseline BMD and visit. Rates of changes in spine BMD after year 1 were estimated in longitudinal mixed models using annual BMD changes as response.